322 related articles for article (PubMed ID: 24258260)
1. Long non-coding RNA HOTAIR is an independent prognostic marker of metastasis in estrogen receptor-positive primary breast cancer.
Sørensen KP; Thomassen M; Tan Q; Bak M; Cold S; Burton M; Larsen MJ; Kruse TA
Breast Cancer Res Treat; 2013 Dec; 142(3):529-36. PubMed ID: 24258260
[TBL] [Abstract][Full Text] [Related]
2. Prognostic impact of HOTAIR expression is restricted to ER-negative breast cancers.
Gökmen-Polar Y; Vladislav IT; Neelamraju Y; Janga SC; Badve S
Sci Rep; 2015 Mar; 5():8765. PubMed ID: 25739705
[TBL] [Abstract][Full Text] [Related]
3. HOTAIR long non-coding RNA is a negative prognostic factor not only in primary tumors, but also in the blood of colorectal cancer patients.
Svoboda M; Slyskova J; Schneiderova M; Makovicky P; Bielik L; Levy M; Lipska L; Hemmelova B; Kala Z; Protivankova M; Vycital O; Liska V; Schwarzova L; Vodickova L; Vodicka P
Carcinogenesis; 2014 Jul; 35(7):1510-5. PubMed ID: 24583926
[TBL] [Abstract][Full Text] [Related]
4. Association of large noncoding RNA HOTAIR expression and its downstream intergenic CpG island methylation with survival in breast cancer.
Lu L; Zhu G; Zhang C; Deng Q; Katsaros D; Mayne ST; Risch HA; Mu L; Canuto EM; Gregori G; Benedetto C; Yu H
Breast Cancer Res Treat; 2012 Dec; 136(3):875-83. PubMed ID: 23124417
[TBL] [Abstract][Full Text] [Related]
5. The long non-coding RNA HOTAIR is upregulated in endometrial carcinoma and correlates with poor prognosis.
He X; Bao W; Li X; Chen Z; Che Q; Wang H; Wan XP
Int J Mol Med; 2014 Feb; 33(2):325-32. PubMed ID: 24285342
[TBL] [Abstract][Full Text] [Related]
6. Impact of FOXA1 expression on the prognosis of patients with hormone receptor-positive breast cancer.
Hisamatsu Y; Tokunaga E; Yamashita N; Akiyoshi S; Okada S; Nakashima Y; Aishima S; Morita M; Kakeji Y; Maehara Y
Ann Surg Oncol; 2012 Apr; 19(4):1145-52. PubMed ID: 21984487
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA HOTAIR is a powerful predictor of metastasis and poor prognosis and is associated with epithelial-mesenchymal transition in colon cancer.
Wu ZH; Wang XL; Tang HM; Jiang T; Chen J; Lu S; Qiu GQ; Peng ZH; Yan DW
Oncol Rep; 2014 Jul; 32(1):395-402. PubMed ID: 24840737
[TBL] [Abstract][Full Text] [Related]
8. Clinical Value of Long Noncoding RNA HOTAIR as a Novel Biomarker in Digestive Cancers: A Meta-Analysis.
Zhang Y; Zhou Y; Xu T; Tian W; Yang C; Wang X; Zhong S; Ran Q; Yang H; Zhu S
Technol Cancer Res Treat; 2018 Jan; 17():1533034618756783. PubMed ID: 29444619
[TBL] [Abstract][Full Text] [Related]
9. LncRNA HOTAIR enhances ER signaling and confers tamoxifen resistance in breast cancer.
Xue X; Yang YA; Zhang A; Fong KW; Kim J; Song B; Li S; Zhao JC; Yu J
Oncogene; 2016 May; 35(21):2746-55. PubMed ID: 26364613
[TBL] [Abstract][Full Text] [Related]
10. Gene expression of topoisomerase II alpha (TOP2A) by microarray analysis is highly prognostic in estrogen receptor (ER) positive breast cancer.
Rody A; Karn T; Ruckhäberle E; Müller V; Gehrmann M; Solbach C; Ahr A; Gätje R; Holtrich U; Kaufmann M
Breast Cancer Res Treat; 2009 Feb; 113(3):457-66. PubMed ID: 18340528
[TBL] [Abstract][Full Text] [Related]
11. A functional HOTAIR rs12826786 C>T polymorphism is associated with breast cancer susceptibility and poor clinicopathological characteristics in a Turkish population: a hospital-based case-control study.
Bayram S; Sümbül AT; Dadaş E
Tumour Biol; 2016 Apr; 37(4):5577-84. PubMed ID: 26577852
[TBL] [Abstract][Full Text] [Related]
12. Expression pattern of stromal cell-derived factor-1 chemokine in invasive breast cancer is correlated with estrogen receptor status and patient prognosis.
Kobayashi T; Tsuda H; Moriya T; Yamasaki T; Kikuchi R; Ueda S; Omata J; Yamamoto J; Matsubara O
Breast Cancer Res Treat; 2010 Oct; 123(3):733-45. PubMed ID: 20020198
[TBL] [Abstract][Full Text] [Related]
13. Breast Cancer: Radiogenomic Biomarker Reveals Associations among Dynamic Contrast-enhanced MR Imaging, Long Noncoding RNA, and Metastasis.
Yamamoto S; Han W; Kim Y; Du L; Jamshidi N; Huang D; Kim JH; Kuo MD
Radiology; 2015 May; 275(2):384-92. PubMed ID: 25734557
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of long noncoding RNA HOTAIR in digestive system malignancies.
Wang S; Wang Z
J Gastroenterol Hepatol; 2015 Jul; 30(7):1123-33. PubMed ID: 25754087
[TBL] [Abstract][Full Text] [Related]
15. Circulating long non-coding HOX transcript antisense intergenic ribonucleic acid in plasma as a potential biomarker for diagnosis of breast cancer.
Zhang Y; Zhang K; Luo Z; Liu L; Wu L; Liu J
Thorac Cancer; 2016 Nov; 7(6):627-632. PubMed ID: 27755794
[TBL] [Abstract][Full Text] [Related]
16. Effect of HOTAIR rs920778 polymorphism on breast cancer susceptibility and clinicopathologic features in a Turkish population.
Bayram S; Sümbül AT; Batmacı CY; Genç A
Tumour Biol; 2015 May; 36(5):3863-70. PubMed ID: 25586347
[TBL] [Abstract][Full Text] [Related]
17. Survival of patients with metastatic breast carcinoma: importance of prognostic markers of the primary tumor.
Chang J; Clark GM; Allred DC; Mohsin S; Chamness G; Elledge RM
Cancer; 2003 Feb; 97(3):545-53. PubMed ID: 12548595
[TBL] [Abstract][Full Text] [Related]
18. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G
Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363
[TBL] [Abstract][Full Text] [Related]
19. Long-Noncoding-RNA HOTAIR Upregulation is Associated with Poor Breast Cancer Outcome: A Systematic Review and Meta Analysis.
Suwardjo S; Gilang Permana K; Aryandono T; Heriyanto DS; Anwar SL
Asian Pac J Cancer Prev; 2024 Apr; 25(4):1169-1182. PubMed ID: 38679975
[TBL] [Abstract][Full Text] [Related]
20. Different prognostic value of cytokeratin-19 mRNA positive circulating tumor cells according to estrogen receptor and HER2 status in early-stage breast cancer.
Ignatiadis M; Xenidis N; Perraki M; Apostolaki S; Politaki E; Kafousi M; Stathopoulos EN; Stathopoulou A; Lianidou E; Chlouverakis G; Sotiriou C; Georgoulias V; Mavroudis D
J Clin Oncol; 2007 Nov; 25(33):5194-202. PubMed ID: 17954712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]